Lam-Hine T, et al.MMWR Morb Mortal Wkly Rep. 2021 Sep 3;70(35):1214-1219. doi: 10.15585/mmwr.mm7035e2.MMWR Morb Mortal Wkly Rep. 2021.PMID: 34473683. Mo Y, et al.Mol Cancer. 2021 Aug 31;20(1):112. doi: 10.1186/s12943-021-01409-4.Mol Cancer. 2021.PMID: 34465340.
.
Effect of Empagliflozin on Worsening Heart Failure Events in Patients with Heart Failure and a Preserved Ejection Fraction: The EMPEROR-Preserved Trial.
Packer M, Butler J, Zannad F, Filippatos G, Ferreira JP, Pocock SJ, Carson P, Anand I, Doehner W, Haass M, Komajda M, Miller A, Pehrson S, Teerlink JR, Schnaidt S, Zeller C, Schnee JM, Anker SD; EMPEROR-Preserved Trial Study Group..
. Avendaño-Solá C, et al.J Clin Invest. 2021 Sep 2:152740. doi: 10.1172/JCI152740. Online ahead of print.J Clin Invest. 2021.PMID: 34473652.
The Influence of Running on Lower Limb Cartilage: A Systematic Review and Meta-analysis.
Khan MCM, O'Donovan J, Charlton JM, Roy JS, Hunt MA, Esculier JF.Khan MCM, et al..